Solomet

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solomet

Quick Facts

Property Description
Active Ingredient Methylprednisolone
Primary Forms Tablet (Oral), Sterile Solution/Powder (Parenteral)
Pharmacological Class Corticosteroid (Glucocorticoid)
General Purpose Suppression of severe inflammation and immune activity
Origin Synthetic (Prednisolone derivative)

What is Solomet and What Class of Medicine is it?

Solomet is a synthetic, prescription-only medicinal preparation containing the powerful active ingredient Methylprednisolone. It is formally classified as a corticosteroid, belonging specifically to the family of glucocorticoids. This designation is clinically recognized for its systemic influence on the body's inflammatory cycles and immune response, a characteristic feature of this drug class. Methylprednisolone is a derivative of prednisolone and exhibits significantly higher anti-inflammatory potency than naturally occurring steroids like hydrocortisone. This high potency means Solomet is typically reserved for conditions requiring a strong and decisive systemic anti-inflammatory effect.

Solomet's Composition and General Purpose

As a single-entity product, the core of Solomet is the sole therapeutic substance, Methylprednisolone. Its general purpose is to provide relief by acting as an agonist on glucocorticoid receptors, thereby controlling excessive or inappropriate immune and inflammatory responses across the body. The widely substantiated efficacy of methylprednisolone has been confirmed across numerous clinical settings. The medication's central benefit is to stabilize the body by powerfully controlling severe, widespread inflammation and overactive immune reactions, such as those encountered in acute allergic or autoimmune crises.

What Physical Forms Does Solomet Come In?

Solomet is offered in the distinct pharmaceutical forms necessary for versatile clinical application. These include the solid tablet for oral administration and sterile liquid solutions or powders intended for parenteral administration. This variety ensures medical professionals can choose the most effective delivery method, allowing for either prolonged management through the oral route or immediate, high-impact intervention via injection, depending on the patient's acute needs.

Regulatory References

  1. Methylprednisolone - StatPearls - NIH
  2. Methylprednisolone - MeSH - NIH

What side effects are possible with Solomet?

Official Safety Profile

As a systemic glucocorticoid, the official safety profile of Solomet (Methylprednisolone) involves documented effects across multiple organ systems. The frequency and severity of many adverse reactions are often linked to the duration of treatment, with the most significant risks generally associated with prolonged use or high-dose exposure.


Systemic Adverse Reaction Classification

Adverse reactions are classified by regulatory authorities across several System-Organ Classes (SOCs):

System Organ Class Documented Effects
Musculoskeletal Muscle weakness, osteoporosis, loss of muscle mass, and avascular necrosis.
Endocrine/Metabolic HPA axis suppression, development of Cushingoid state, fluid retention, and decreased carbohydrate tolerance.
Gastrointestinal Peptic ulceration with possible hemorrhage or perforation, and pancreatitis.
Nervous/Psychiatric Mood changes, insomnia, vertigo, and increased intracranial pressure (pseudotumor cerebri) upon cessation.
Ophthalmic Posterior subcapsular cataracts and glaucoma.

Serious Safety Considerations

Officially documented serious adverse reactions include peptic ulcer perforation, aseptic necrosis of bone, and severe adrenocortical insufficiency upon abrupt withdrawal of the medication. The medication is contraindicated in patients with systemic fungal infections. Serious neurologic events, such as spinal cord infarction, have been reported following the use of the unapproved epidural route of administration.

Population and Duration Notes

The label includes specific safety considerations, such as the risk of growth suppression in the pediatric population and a higher risk of osteoporosis and hypertension in older adults. Adrenocortical unresponsiveness can persist for months after treatment is discontinued.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents indicate that Solomet (Methylprednisolone) does not present with a recognizable clinical syndrome of acute overdosage. Acute toxicity and death following an overdose are formally described as rare events, and an acute excess is generally not expected to produce immediate life-threatening symptoms.

Documented Manifestations

Manifestations of excessive steroid exposure are typically associated with long-term use of high steroid doses. These effects on the physiological systems may include thinning skin, easy bruising, and changes in body fat distribution (Cushingoid features). Specific impacts noted in official documents include menstrual problems and impotence or loss of interest in sex in adults.

Emergency Actions Mandated by Regulators

Regulatory guidance mandates that individuals seek emergency medical attention or contact the Poison Help line immediately following any suspected overdose. Urgent medical help must be sought immediately if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

There is no specific antidote available for Solomet overdose. Treatment is strictly defined as supportive and symptomatic measures. In a medical setting, monitoring includes the assessment of vital signs, and the regulatory profile notes that methylprednisolone is dialyzable.

Therapeutic Uses of Solomet

What Solomet Treats: Main Uses and Benefits

Solomet is commonly used when short-term symptomatic assistance is needed across conditions where symptoms may intensify temporarily and involve inflammatory or irritative processes. It is generally applied in clinical settings that involve acute or unstable symptom patterns.

The medication is relevant for easing symptom clusters that may become intense or disruptive in conditions such as acute flares of Rheumatoid Arthritis and Systemic Lupus Erythematosus, allergic reactions associated with acute changes, asthma exacerbations where symptoms may intensify temporarily, Inflammatory Bowel Disease (IBD), and certain neurological disorders like Multiple Sclerosis. It is particularly used when symptoms create noticeable physiological strain and interfere with daily functioning.

“The medication helps address symptom clusters that may become intense or disruptive, supporting the handling of distressing manifestations.”

In these scenarios, Solomet provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of acute disease activity.


Quick Fact: Relief for Symptoms Related to Inflammation

Property Description
Primary Goal Symptomatic support during acute flares
Symptoms Targeted Pain, swelling, restricted movement, symptoms that create noticeable physiological strain
Typical Context Short-term management of acute or unstable symptom patterns
Patient Benefit Helps patients cope more steadily with difficult episodes

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Solomet (Methylprednisolone) is authorized for use in adults and pediatric patients under specific conditions. Its eligibility profile is strictly defined by regulatory authorities to ensure patient safety and is structured around absolute prohibitions and conditional requirements.

Contraindications (Must Not Use): The medication is contraindicated in patients with a known systemic fungal infection or documented hypersensitivity to Solomet or its components. It must also not be given to patients receiving immunosuppressive doses who require live or live-attenuated vaccines. Furthermore, specific routes of administration, such as intrathecal and epidural injection, are not permitted.

Conditional and Restricted Use: Caution is required for patients with pre-existing comorbidities. This includes gastrointestinal disorders (e.g., active peptic ulcer, diverticulitis), cardiovascular conditions (e.g., congestive heart failure), and certain endocrine conditions like diabetes mellitus or cirrhosis. Use in latent tuberculosis requires close observation and, potentially, concurrent chemoprophylaxis.

Age and Reproductive Status: In the pediatric population, use requires monitoring for potential growth suppression. Formulations containing benzyl alcohol are contraindicated in premature infants. During pregnancy and lactation, use is strictly conditional, requiring a clear determination that the potential benefit outweighs the potential hazards to the fetus or infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Solomet (Methylprednisolone) establishes specific interaction patterns based on how the body processes the drug and its effects on other co-administered substances.

Drug–Drug and Metabolic Interactions

Solomet is primarily metabolized by the CYP3A4 enzyme and is documented to potentially be a P-glycoprotein (P-gp) substrate. Co-administration with CYP3A4 inhibitors (such as certain antifungals, including Ketoconazole) is documented to result in increased plasma concentrations of Solomet. Conversely, CYP3A4 inducers (including specific anticonvulsants like Phenytoin or Phenobarbital) lead to decreased plasma concentrations, which may reduce effectiveness.

Pharmacodynamic and Formal Restrictions

Specific contraindications are established in regulatory labeling. The co-administration of Solomet with live or live, attenuated vaccines is contraindicated when the drug is used at immunosuppressive doses. The drug is also formally prohibited in the presence of systemic fungal infections.

Additive pharmacodynamic effects are documented, notably the combination with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), which carries an additive toxicity risk for gastrointestinal ulceration and hemorrhage. Combining Solomet with certain diuretics also poses an additive risk for hypokalemia (low potassium).

Food and Substance Modulators

Grapefruit/Grapefruit Juice is noted as a substance that may inhibit Solomet’s metabolism, potentially increasing drug plasma levels. Furthermore, the corticosteroid effect is officially enhanced in specific patient populations, including those with underlying conditions such as Cirrhosis or Hypothyroidism.

Mechanism of Action

How Solomet Works

Solomet (Methylprednisolone) achieves its actions by modulating cellular function at the genomic level, affecting the body's inflammatory and immune pathways.


Modulating Genes via the Glucocorticoid Receptor

The foundational mechanism involves Solomet acting as an Agonist that binds to the intracellular Glucocorticoid Receptor (GR/NR3C1). This activated complex then enters the cell nucleus, where it performs Transrepression, directly inhibiting master inflammatory transcription factors like NF-kappaB. This action switches off genes that instruct the cell to produce inflammatory substances, thereby initiating a widespread physiological effect of reducing inflammatory signaling.


Affecting Multiple Inflammatory and Immune Cascades

The direct genomic modulation results in the modulation of multiple components of the inflammatory cascade. This includes indirectly inhibiting the enzyme Phospholipase A2 ( PLA2), which reduces the formation of key mediators like prostaglandins and leukotrienes, and lowering the production of pro-inflammatory cytokines (e.g., IL-6). The mechanism also impairs the migration, proliferation, and function of immune cells, contributing to overall reduction in immune cell functionality and attenuating the cellular response in affected tissues.

Dosage and Administration Information

Administration Guidelines for Solomet

Solomet (methylprednisolone) is used systemically via oral tablets and intravenous (IV) or intramuscular (IM) injection, or for localized treatment via intra-articular and soft tissue injection. The medication's usage is defined by specific instructions covering dosing, frequency, and time-related administration.


Dosing and Administration

Instruction Detail
Dosing Range Initial daily dosage for systemic use is generally 4 mg to 48 mg, determined by the severity of the condition and patient response. Acute, severe episodes may require high-dose IV pulse therapy, such as 30 mg/kg administered over at least 30 minutes.
Frequency & Timing Oral tablets may be taken once daily or in divided doses; for single-dose regimens, the morning is generally preferred. When using the parenteral form, repeated injections may be required every 4 to 6 hours for maintaining consistently high blood levels.
Age-Group Rules Dosage for pediatric patients is primarily based on the severity and response to the condition, rather than solely on age or size. The systemic dose should not be less than 0.5 mg/kg every 24 hours.

Procedural Requirements

  • Oral Intake: Tablets may be taken with food to help minimize potential gastrointestinal irritation.
  • IV Preparation: The powder for IV/IM injection must be reconstituted with a specified diluent before use. Larger IV doses (exceeding 250 mg) must be administered over a period of at least 30 minutes.
  • Withdrawal: If the medication has been administered for more than a short duration, the drug must be withdrawn gradually (tapered) according to a schedule to allow the body to adjust.

The core protocol dictates that Solomet is started at an effective dose, then adjusted down to the lowest possible dose that maintains the clinical response, followed by a gradual reduction if the treatment is discontinued.

Recent Clinical Evidence

Research evidence / Overview of studies for Solomet

The research for Solomet examined conditions characterized by fluctuating or episodic manifestations. The evidence comes from a variety of studies, including those relevant in trials assessing short-term or episodic symptom patterns and applied in observational settings evaluating daily-life functioning. Research efforts have explored patient-reported experiences to understand outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.


Indication 1: Conditions involving periods of heightened symptoms

The initial research for Solomet was studied for conditions involving periods of heightened symptoms. These studies monitored outcomes related to systemic or functional imbalance over defined time intervals. Research examined how symptoms evolved in the observed populations during periods of increased symptom activity.

For this group of conditions, data show patterns related to changes measured during the study period, specifically for outcomes describing episodic or acute changes. Studies report patterns related to the observation of changes in the frequency of phases of heightened symptom activity. However, it is important to understand that research provides context but not individual predictions; findings describe group patterns, not personal outcomes.

Research exploring short-term symptom changes

Research specifically focusing on episodes where symptoms become more noticeable has explored the short-term symptom changes. Findings from some studies contribute to understanding symptom patterns over the defined, short time frames. However, follow-up durations were limited in these studies. Therefore, long-term effects are not fully established, and data are still emerging.


Indication 2: Conditions characterized by functional limitations

Solomet was studied for conditions marked by functional limitations. Research here focused on outcomes reflecting daily functioning or activity level. In these contexts, the findings describe patterns observed in studies where Solomet was observed in certain populations. Research describes changes measured during the study period for outcomes linked to inflammatory or irritative states. Studies exploring these conditions often used observational settings evaluating daily-life functioning.

Limitations and Uncertainties

Comparative evidence is lacking for some of the related conditions, and certainty remains low for outcomes over extended time periods. Research does not determine whether an individual will respond similarly to the group patterns reported, as study results reflect the specific conditions under which they were conducted. The evidence highlights what is known—and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Solomet (FAQ)

Q: Can Solomet be taken long-term?

Official product information indicates that the dosage must always be individualized based on the condition being treated. If the medicine is used for a prolonged duration, it is typically advised to be withdrawn gradually (tapered) to allow the body to adjust. Long-term use is associated with known risks such as bone thinning (osteoporosis) and potential growth suppression in children.

Q: Does Solomet make you tired or dizzy?

Regulatory documents list both dizziness (vertigo) and unusual tiredness or weakness as documented side effects. These feelings can sometimes be related to the drug's effect on the body's natural hormones, such as when the adrenal glands are suppressed.

Q: How does Solomet compare to [Name of similar drug]?

Solomet contains methylprednisolone, which is classified as a potent glucocorticoid medicine. Official sources indicate that methylprednisolone exhibits greater anti-inflammatory potency than prednisolone. It is described as having less of a tendency to cause the body to retain sodium and water compared to prednisolone.

Q: Do I need to change my diet while on Solomet?

Regulatory information emphasizes the need for careful monitoring, which can include keeping daily weight records and monitoring fluid intake. For patients with diabetes, regulatory information indicates that diet or diabetes medications may require adjustment during treatment due to the drug's potential to increase blood sugar levels.

Q: Are there any special warnings for people with kidney or liver issues?

Official warnings state that caution is required when the drug is used by patients with pre-existing liver disease, such as cirrhosis or hepatitis. While general dosing is not typically changed for kidney failure, the risk of fluid retention may cause complications for individuals with kidney disease.

Q: Is Solomet related to any medications used for pain relief?

Solomet is classified as a glucocorticoid (a type of steroid) and is primarily prescribed for its powerful anti-inflammatory effects, not as a general pain reliever. Official documentation notes an additive toxicity risk when Solomet is combined with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), a common type of pain medicine.

Q: If I have a mild case, will Solomet be too strong?

Official guidelines state that the initial dosage is determined by the severity of the condition being treated. In situations described as less severe, lower starting doses are generally considered sufficient. Dosage requirements are typically individualized to achieve the lowest possible effective dose.

Q: Can I take Solomet if I have a history of depression?

Regulatory sources state that the drug is advised to be used with caution in patients with a history of affective disorders, which includes conditions like depression. These warnings are in place due to the risk of documented nervous system and psychiatric effects.

Q: What is Solomet used for besides the main condition?

According to official product labeling, Solomet is indicated for the treatment of numerous conditions based on its strong anti-inflammatory effects. These include severe allergies, certain types of arthritis, blood disorders, and specific conditions affecting the lungs (e.g., asthma), eyes, and skin.

Q: How quickly does Solomet start working?

Official pharmacological data indicates that following oral intake, the concentration of the drug in the blood generally peaks in approximately 1.5 to 2.3 hours. When given intravenously, demonstrable effects are often seen more quickly, sometimes within one hour of administration.

Q: What happens if I forget a dose of Solomet?

Regulatory guidelines on missed doses advise taking it as soon as possible if one is forgotten. However, if it is almost time for the next scheduled dose, the missed dose is typically advised to be skipped. It is specified not to double the dose to make up for the one missed.

Q: Does Solomet cause weight gain or weight loss?

Regulatory information notes that weight gain is a documented effect of this class of medication, often due to an increase in appetite or the body retaining fluid. Less commonly, weight loss has also been reported as a side effect.

Q: Are the side effects of Solomet permanent?

Official safety information indicates that many side effects, such as psychiatric symptoms, are described as reversible once treatment is stopped or the dosage is lowered. However, certain risks, like bone thinning, are associated with the duration of use and typically require professional monitoring.

Q: Is there a generic version of Solomet available?

The active ingredient in Solomet is methylprednisolone. This ingredient is available under its generic name, as well as under several different brand names authorized by regulatory bodies.

Q: How long does Solomet stay in your system?

Pharmacological data indicates the mean elimination half-life for the drug ranges between 1.8 and 5.2 hours. This means that after taking an oral tablet, the drug is expected to be largely cleared from the body within approximately 13 to 20 hours.

Q: Is it normal to feel a bit nauseous when first starting Solomet?

According to regulatory safety profiles, nausea and vomiting are listed among the possible side effects associated with the use of this medication.

Q: What if I accidentally take two doses of Solomet?

Official guidelines on missed doses advise against doubling the dose to compensate for a forgotten one. General information on accidental overdose suggests that such situations are typically managed through consultation with a healthcare professional or poison control center.

Q: Can Solomet interact with birth control pills?

The drug is documented to cause menstrual irregularities due to its effect on the endocrine system (hormones). Official information states that patients using oral contraceptives are advised to consult with a prescriber about the possibility of this effect occurring.

Q: Will Solomet show up on a drug test?

Although Solomet contains a steroid, the active ingredient is not generally included in standard drug test screenings. However, specialized laboratory tests designed specifically to detect corticosteroids may be able to identify it.

Q: Does Solomet lose its effectiveness over time?

Official prescribing information indicates that the dosage is maintained or adjusted until a satisfactory effect is noted. If a lack of satisfactory clinical response is observed after a reasonable treatment time, the medication may be discontinued, suggesting that continued monitoring of the dosage may be important to maintain effectiveness.

Q: Is Solomet intended to cure the condition or just manage symptoms?

Official product labeling indicates that the medicine is used for the management of various conditions due to its powerful anti-inflammatory and immunosuppressive effects. The regulatory language describes a role in controlling symptoms rather than providing a cure.

Q: Are there different strengths of Solomet tablets?

According to official product listings, Solomet oral tablets containing methylprednisolone are manufactured in multiple strengths. These strengths include 2 mg, 4 mg, 8 mg, 16 mg, and 32 mg.

Q: How long before surgery should I stop taking Solomet?

Official safety information notes that dosage may require adjustment during periods of high physical stress, such as trauma or surgery. This is due to the documented risk of secondary adrenocortical unresponsiveness after stopping the medicine.

Q: What happens when the effects of Solomet wear off?

When the medication is discontinued, it is advised to be done gradually. Regulatory information warns that abrupt withdrawal after chronic use carries the risk of acute adrenal insufficiency. Symptoms of this condition can include feelings of general discomfort (malaise), muscle weakness, nausea, and vomiting.

How should Solomet be stored and disposed of?

How to Store and Dispose of Solomet (Methylprednisolone)

The official storage conditions for methylprednisolone vary by formulation, as specified in regulatory labeling.

Formulation Required Storage Condition Stability/Handling Rules
Sterile Powder (Unreconstituted) Store at Controlled Room Temperature (20 C to 25 C) and protect from light. Must be used within 48 hours after reconstitution.
Oral Tablets Store at room temperature. Keep in the original container, tightly closed. Must be kept away from excess heat and moisture and must not freeze.

All forms of this medication must be kept out of the sight and reach of children. Unused or expired Solomet must be disposed of in accordance with local and national regulations, and it should not be discarded into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solomet found in:

A-Z Index: